Comparison of clinical parameters in patients with different hematologic stages of erythrodermic cutaneous T-cell lymphoma
| Hematological stage . | Patients, no. . | Mean age at dx, y (range) . | Mean follow-up, y (range) . | Mean CD4:CD8 ratio (range) . | Deaths, no. . | Death rate y 1 . | CTCL deaths no. . | Death rate from CTCL y 1 . |
|---|---|---|---|---|---|---|---|---|
| H0 | 3 | 47 (43-53) | 11 (9-12) | 1.7 (1.4-2.0) | 1 | 0.03 | 0 | 0 |
| H1 | 8 | 65 (38-84) | 6.6 (2-20) | 1.9 (1.0-3.0) | 2 | 0.04 | 1 | 0.02 |
| H0 and H1 | 11 | 60 (38-84) | 7.8 (2-20) | 1.8 (1.0-3.0) | 3 | 0.035 | 1 | 0.01 |
| H2 | 14 | 60 (49-71) | 3.9 (1-9) | 6.6 (1.6-15.3) | 9 | 0.16 | 6 | 0.11 |
| H3 | 24 | 64 (38-79) | 3.4 (1-7) | 22.9 (1.55-99.0) | 19 | 0.23 | 15 | 0.18 |
| H4 | 8 | 67 (59-77) | 3.0 (1-5) | 61.1 (20.4-99) | 6 | 0.25 | 6 | 0.25 |
| Hematological stage . | Patients, no. . | Mean age at dx, y (range) . | Mean follow-up, y (range) . | Mean CD4:CD8 ratio (range) . | Deaths, no. . | Death rate y 1 . | CTCL deaths no. . | Death rate from CTCL y 1 . |
|---|---|---|---|---|---|---|---|---|
| H0 | 3 | 47 (43-53) | 11 (9-12) | 1.7 (1.4-2.0) | 1 | 0.03 | 0 | 0 |
| H1 | 8 | 65 (38-84) | 6.6 (2-20) | 1.9 (1.0-3.0) | 2 | 0.04 | 1 | 0.02 |
| H0 and H1 | 11 | 60 (38-84) | 7.8 (2-20) | 1.8 (1.0-3.0) | 3 | 0.035 | 1 | 0.01 |
| H2 | 14 | 60 (49-71) | 3.9 (1-9) | 6.6 (1.6-15.3) | 9 | 0.16 | 6 | 0.11 |
| H3 | 24 | 64 (38-79) | 3.4 (1-7) | 22.9 (1.55-99.0) | 19 | 0.23 | 15 | 0.18 |
| H4 | 8 | 67 (59-77) | 3.0 (1-5) | 61.1 (20.4-99) | 6 | 0.25 | 6 | 0.25 |
Dx indicates diagnosis; y, year; CTCL, cutaneous T-cell lymphoma.